230 related articles for article (PubMed ID: 277222)
21. [Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
Ono K; Takahashi M; Hamanaka D; Hiraoka M; Nishidai T; Abe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):370-6. PubMed ID: 6223274
[No Abstract] [Full Text] [Related]
22. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
Hokland SL; Horsman MR
Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
[TBL] [Abstract][Full Text] [Related]
23. [Cancer and radiotherapy. (4). Hypoxic cell sensitizers and hyperthermia combined with radiation in cancer treatment].
Abe M; Takahashi M; Ono K; Hiraoka M
Iyodenshi To Seitai Kogaku; 1982 Jun; 20(3):203-9. PubMed ID: 6759728
[No Abstract] [Full Text] [Related]
24. The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
Horsman MR; Overgaard J; Chaplin DJ
Acta Oncol; 1988; 27(6b):861-2. PubMed ID: 3233175
[No Abstract] [Full Text] [Related]
25. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
[TBL] [Abstract][Full Text] [Related]
26. [Effect of the hypoxic cell radiosensitizer,a dinitroimidazole derivative, on murine tumors].
Tanaka M; Nakajima T; Fukuda H; Kida A; Tsumura M; Sakashita M; Onoyama Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Dec; 46(12):1442-3. PubMed ID: 3822789
[No Abstract] [Full Text] [Related]
27. The effect of misonidazole in combination with radiation dose fractionation.
Hill RP; Bush RS
Br J Cancer Suppl; 1978 Jun; 3():255-8. PubMed ID: 277242
[TBL] [Abstract][Full Text] [Related]
28. The effects of misonidazole during continuous low dose rate irradiation.
Fu KK; Hurst S; Begg AC; Brown JM
Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
[TBL] [Abstract][Full Text] [Related]
29. Histopathological changes in transplanted mouse mammary carcinoma following hyperthermia with or without radiation.
Jo S; Hiraoka M; Akuta K; Nishimura Y; Furuta M; Takahashi M; Abe M
Jpn J Cancer Res; 1986 Nov; 77(11):1095-101. PubMed ID: 3098719
[TBL] [Abstract][Full Text] [Related]
30. Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
Goldfeder A; Brown DM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1287-91. PubMed ID: 6469752
[TBL] [Abstract][Full Text] [Related]
31. Effect of hyperthermia on the hypoxic fraction in an experimental mammary carcinoma in vivo.
Overgaard J
Br J Radiol; 1981 Mar; 54(639):245-9. PubMed ID: 7470787
[TBL] [Abstract][Full Text] [Related]
32. Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo.
Kamura T; Nielsen OS; Overgaard J; Andersen AH
Cancer Res; 1982 May; 42(5):1744-8. PubMed ID: 7066896
[TBL] [Abstract][Full Text] [Related]
33. Contrasting regrowth delay responses of a murine tumour to isocurative hyperthermia or X irradiation.
Walker A; Wheldon TE; Brunton GF; Abdelaal AS
Br J Radiol; 1982 Oct; 55(658):780-2. PubMed ID: 7127032
[No Abstract] [Full Text] [Related]
34. The effect of hyperthermia on radiation-induced carcinogenesis.
Baker DG; Constable WC; Sager H; Kaiser DL
Radiat Res; 1988 Sep; 115(3):448-60. PubMed ID: 3174929
[TBL] [Abstract][Full Text] [Related]
35. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
[No Abstract] [Full Text] [Related]
36. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
Rockwell S
Br J Cancer Suppl; 1978 Jun; 3():212-5. PubMed ID: 277230
[TBL] [Abstract][Full Text] [Related]
37. Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo.
Mao HS; Grau C; Overgaard J
Int J Radiat Oncol Biol Phys; 1992; 22(1):115-22. PubMed ID: 1727107
[TBL] [Abstract][Full Text] [Related]
38. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
[TBL] [Abstract][Full Text] [Related]
39. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells.
Wondergem J; Haveman J; van der Schueren E; van den Hoeven H; Breur K
Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1323-31. PubMed ID: 7141911
[TBL] [Abstract][Full Text] [Related]
40. Radiosensitization of tumors and normal tissues by combined treatment with misonidazole and heat.
Hofer KG; MacKinnon AR; Schubert AL; Lehr JE; Grimmett EV
Radiology; 1981 Dec; 141(3):801-9. PubMed ID: 7302238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
